Retinal Degenerations Completed Phase 2 Trials for Valproic acid (DB00313)

Also known as: Retinal Degeneration / Degeneration retinal

IndicationStatusPhase
DBCOND0041282 (Retinal Degenerations)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01399515Efficacy and Safety of Oral Valproic Acid for Retinitis PigmentosaTreatment